Processa Pharmaceuticals, Inc.

PCSA·NasdaqCM·Healthcare
Compare
1.9350−0.0050 (−0.26%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.9400
Open1.8600
Day range1.83001.9500
52-week range1.04108.8800
Off day high−0.77%
Off 52-week high−78.21%
Volume21.56K
Avg. volume (3M)85.19K
Market cap5.41M
EPS (TTM)-4.33
Forward P/E-0.52
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.23
Shares outstanding2.80M
Short interest1.93% of float
Earnings dateAug 11, 2025 (est.)
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
PCSA TPST NCNA RKV.V ATORX.ST LTRN
Market cap 5.41M 9.26M 4.25M 4.27M 38.54M 8.76M
P/E (TTM) — — — — — —
Forward P/E -0.5 -0.4 -0.1 — -0.1 -0.3
Price/book -17.0 -6.8 0.2 -2.0 0.3 -2.3
Dividend yield — — — — — —
1-year change −75.51% −95.15% −73.68% +2.94% −99.44% −82.53%
Today −0.26% −1.13% +0.99% 0.00% +0.93% −2.61%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Processa Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Tempest Therapeutics, Inc.TPST · Biotechnology 9.26M 0.4633 −1.13%
NuCana plcNCNA · Biotechnology 4.25M 1.0200 +0.99%
Rakovina Therapeutics Inc.RKV.V · Biotechnology 4.27M 0.1750 0.00%
Alligator Bioscience AB (publ)ATORX.ST · Biotechnology 38.54M 0.0108 +0.93%
Lantern Pharma Inc.LTRN · Biotechnology 8.76M 0.5866 −2.61%
Cellectar Biosciences, Inc.CLRB · Biotechnology 11.63M 1.2300 −6.11%
Allarity Therapeutics, Inc.ALLR · Biotechnology 17.18M 1.0800 −4.42%
Curis, Inc.CRIS · Biotechnology 7.41M 1.1100 +55.48%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
COSCIENS Biopharma Inc.ET80.F · Toronto, ON 5.30M 5.31 +0.95%
Pulmatrix, Inc.PULM · Framingham, MA 5.55M 1.5200 +14.29%
Addex Therapeutics LtdADXN · Geneva, Switzerland 5.33M 3.0431 +1.27%
PharmaTher Holdings Ltd.PHRM.CN · Toronto, ON 4.55M 0.0500 −16.67%
Evogene Ltd.EVGN · Rehovot, Israel 6.41M 0.3568 +1.25%
Imunon, Inc.IMNN · Lawrenceville, NJ 5.09M 0.9070 +0.78%
Niki BioSolutions, Inc.NIKI · Princeton, NJ 5.27M 1.6900 −3.98%
Biotron LimitedBIT.AX · Sydney, NSW 5.57M 0.0020 +100.00%

Also based in Vero Beach, Florida, then elsewhere in Florida.

Company Mkt cap Price Today
ARMOUR Residential REIT, Inc.ARR · Vero Beach, FL 1.78B 12.60 +3.87%
Orchid Island Capital, Inc.ORC · Vero Beach, FL 957.24M 4.9600 +3.55%
Royal Caribbean Cruises Ltd.RCL · Miami, FL 89.11B 333.15 +6.38%
L3Harris Technologies, Inc.LHX · Melbourne, FL 48.36B 259.74 −6.46%
NextEra Energy, Inc.NEE · Juno Beach, FLOdds 185.51B 88.45 +4.89%
Carnival Corporation Ltd.CCL · Miami, FLOdds 42.11B 31.32 +7.26%
Palantir Technologies Inc.PLTR · Aventura, FLOdds 413.71B 171.70 −2.11%
Lennar CorporationLEN · Miami, FL 21.93B 92.19 +7.09%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All PCSA news ›
The Globe and Mail·Negative

Processa Pharmaceuticals Relocates 2025 Stockholder Meeting

Processa Pharmaceuticals ( (PCSA) ) has issued an announcement. On August 25, 2025, Processa Pharmaceuticals, Inc. announced a change in the location for its 2025 Special Meeting of Stockholders. The meeting was moved from Vero Beach, FL…

PCSA
The Globe and Mail·Negative

Processa Pharmaceuticals Raises $1.3M in Private Placement

The latest update is out from Processa Pharmaceuticals ( (PCSA) ). The most recent analyst rating on (PCSA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Processa Pharmaceuticals stock, see the PCSA…

PCRXPRAAPCSA
The Globe and Mail·Negative

Processa Pharmaceuticals Announces Reverse Stock Split

Processa Pharmaceuticals ( (PCSA) ) just unveiled an announcement. On December 12, 2025, Processa Pharmaceuticals announced a 1-for-25 reverse stock split of its common stock, effective December 16, 2025. This move, which will see the…

The Globe and Mail·

Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance

Processa Pharmaceuticals ( (PCSA) ) has shared an update. The most recent analyst rating on (PCSA) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Processa Pharmaceuticals stock, see the PCSA Stock…

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Mixedsentiment

Mentioned with

Nasdaq Capital Market6Processa5U.S. Food and Drug Administration5Pacira Biosciences4Pfizer4Atea Pharmaceuticals3Pacira Biosciences, Inc3Pacira Pharmaceuticals3

People in the coverage

Processa8Michael Walen5Pacira4Tristan Rich4Viatris3Abdolreza Yaqoubzadeh2

Themes

Healthcare9Pharmaceuticals7Biotechnology6SEC Filings6Cancer3Pharma3Results3Announces2

Most coverage from

  1. theglobeandmail.com11
  2. kalkinemedia.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance